Theravance Biopharma Inc
NASDAQ:TBPH
Theravance Biopharma Inc
EPS (Diluted)
Theravance Biopharma Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theravance Biopharma Inc
NASDAQ:TBPH
|
EPS (Diluted)
-$1
|
CAGR 3-Years
39%
|
CAGR 5-Years
24%
|
CAGR 10-Years
15%
|
See Also
What is Theravance Biopharma Inc's EPS (Diluted)?
EPS (Diluted)
-1
USD
Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's EPS (Diluted) amounts to -1 USD.
What is Theravance Biopharma Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
15%
The average annual EPS (Diluted) growth rates for Theravance Biopharma Inc have been 39% over the past three years , 24% over the past five years , and 15% over the past ten years .